Connect to share and comment

Female migrants crossing into U.S. turn to contraceptives amid rape fears

Tucson, Arizona, Apr 9 (EFE).- Quite apart from the risks inherent in crossing the U.S. border illegally, a large number of women decide to take contraceptive pills to prevent unwanted pregnancies knowing that the possibility also exists that they might be raped on their journey to the United States.

US top court weighs religious rights over birth control

Hobby Lobby's 556 arts and crafts stores across the United States are closed on Sundays, and billionaire CEO David Green says the chain's true owner is God. His religious beliefs put him at odds with health care laws demanding the company provide contraceptive options in its employee health plans. And so US Supreme Court justices will hear oral arguments Tuesday in a high-stakes religious freedom case brought by Green's firm.

Educating young men could expand ‘morning after pill' use

By Shereen Jegtvig NEW YORK (Reuters Health) - Young men know even less about emergency contraception than young women do, which may be limiting access to an effective means of preventing unwanted pregnancies, researchers say. "The big finding in our study is that young men had a lot less knowledge about emergency contraception than the young women that we surveyed, and even among the young women, knowledge wasn't great," Sheree Schrager, a member of the study team, told Reuters Health.

Merck to pay $100 million in NuvaRing contraceptive settlement

(Reuters) - Merck & Co said on Friday it will pay $100 million to resolve all U.S. product liability lawsuits alleging it downplayed serious health risks involving its NuvaRing intrauterine contraceptive device.

Health Canada studying 'morning-after pill' after questions about its efficacy

TORONTO - Health Canada says it is studying the effectiveness of the so-called "morning after" contraceptive pills in the wake of news they don't as well in larger women. The federal drug regulator says it is assessing new data that suggests a higher body weight could reduce the effectiveness of emergency contraceptives. Health Canada says it is also looking at whether labelling changes are needed for all brands of the pills to reflect the problem.

Europe assessing if weight affects 'morning after pill' success

LONDON (Reuters) - European regulators said on Friday they would assess whether emergency contraceptives, known as the "morning after pill" worked as effectively in women weighing more than 75 kilograms, and whether the warning labels should be changed. The review was requested by the Swedish medicines regulatory agency, which decided in November to amend the product information for Norlevo, which contains levonorgestrel, the European Medicines Agency said.

Bayer says reintroducing Diane-35 in France

FRANKFURT (Reuters) - German drugmaker Bayer AG said on Wednesday it was cleared by the French health authority to reintroduce oral acne treatment Diane-35 to the French market after an eight-month suspension. The European Commission said in July that Diane-35 was safe for use, a seal of approval which obliged France to allow sales of the product again. France had suspended sales of Diane-35 after four deaths over the past 25 years were linked to its use.

US court blocks contraception clause in health care law

A US Supreme Court justice has blocked a stipulation in the new health care reform law that requires some religion-affiliated organizations to provide insurance that includes birth control. Justice Sonia Sotomayor acted late Tuesday just hours before the Affordable Care Act law was to take effect, in response to an order of nuns in Colorado, US media reported. She gave the government until Friday morning to file briefs on the matter. The contraception requirement has been one of the most controversial aspects of the health law.

FDA rejects Actavis' contraceptive patch, seeks more data

(Reuters) - Actavis Plc said U.S. health regulators denied approval to its contraceptive patch for women and asked for more data. The U.S. Food and Drug Administration questioned the differences in size and formulation of the patch used in trials and the to-be-marketed patch. The generic drugs maker, which received a "complete response letter" from the FDA, said it planned to work closely with the agency to address the questions.

Business Highlights

___ Global free trade talks collapse GENEVA (AP) — Negotiators came tantalizingly close but failed to clinch a global free trade deal after more than a decade of talks that could have boosted the world economy by $1 trillion, the head of the World Trade Organization said Tuesday. Diplomats from the WTO's 159 members were trying to reach an agreement ahead of a summit next week in Bali, Indonesia where ministers were to have signed the deal.
Syndicate content